LAZR - SFIX AR among premarket gainers
Curis CRIS +199% on encouraging CA-4948 data in leukemia.NeuroMetrix (NURO) +84%.Stitch Fix SFIX +39% on Q1 results.Lexicon Pharmaceuticals (LXRX) +31%.Cancer Genetics (CGIX) +28%.Smartsheet SMAR +18% on Q3 results.Tarena TEDU +18% on founder's going private proposal at $4/ADS.Platinum Group Metals (PLG) +17%.Hollysys Automation Technologies HOLI +17% on takeout proposal at $15.47/share.QuantumScape (QS) +15% on performance data for its solid-state battery technology.CLPS (CLPS) +14% on deal with a client in automotive industry for big data- enabled vehicle intelligent manufacturing system.Foley Trasimene Acquisition II (BFT) +13%.Liquidity Services LQDT +12% on FQ4 results.electroCore (ECOR) +5% on positive top-line results from premium II migraine prevention study.Uranium Energy (UEC) +10%.Mereo BioPharma (MREO) +10%.Futu Holdings FUTU +10% on selling securities for an aggregate $260M.Velodyne Lidar (VLDR) +9% as Velodyne’s Velarray H800 and PAEB Solution to power advanced driver assistance systems and autonomy.Luminar Technologies (LAZR) +9%.InterPrivate Acquisition (IPV) +9%.HL Acquisitions (HCCH) +8%.Antero Resources (AR) +7%.Ampio Pharmaceuticals (AMPE) +7%.MP Materials (MP) +7%.Nano Dimension (NNDM) +7%.
For further details see:
SFIX, AR among premarket gainers